US Patent Issued to Dana-Farber Cancer Institute on Aug. 11 for "Methods for identification, assessment, prevention, and treatment of metabolic disorders using SLIT2" (California, Massachusetts Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,702,694, issued on Aug. 11, was assigned to Dana-Farber Cancer Institute Inc. (Boston).

"Methods for identification, assessment, prevention, and treatment of metabolic disorders using SLIT2" was invented by Bruce M. Spiegelman (Waban, Mass.) and Katrin J. Svensson (Palo Alto, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to methods for identifying, assessing, preventing, and treating metabolic disorders and modulating metabolic processes using Slit2."

The patent was filed on Feb. 28, 2022, under Application No. 17/682,454.

*For further information, including images, charts and tables, please visit: http://patft.us...